Anish BhatnagarCEO at Soleno TherapeuticsSpeaker
Profile
Dr. Bhatnagar, CEO of Soleno since its inception in 2017, brings over 20 years of medical expertise to the biopharmaceutical and medical device industries. His extensive background encompasses the development of biologics, drugs, drug-device combinations, and diagnostic/therapeutic medical devices. Notable contributions include products like Bexxar, Probuphine, Serenz, and CoSense. Prior to Soleno, he served as CEO of Capnia, Inc. His career journey includes roles at Coulter Pharmaceuticals, Inc. and Titan Pharmaceuticals, Inc. Dr. Bhatnagar, a published author, earned his medical degree at SMS Medical College, Jaipur, India, and completed Residency and Fellowship training at institutions including Georgetown University Hospital and the University of Pennsylvania.
Agenda Sessions
Navigating the Unchartered – Fireside Chat with Rare Disease Pharma Pioneers
, 5:00pmView Session